CONCORD, North Carolina (AP) — Pharmaceutical giant Eli Lilly and Co. will build a new manufacturing facility in central North Carolina on the site of a former cigarette factory that once attracted other companies to the region.
Eli Lilly, who made the announcement Friday with government officials, plans a five-building campus at The Grounds economic development site in Concord, media reported. The investment of nearly $1 billion will lead to nearly 600 jobs that will offer average salaries of nearly $70,000.
Indianapolis-based Eli Lilly will make parenteral — or injectable — products and devices at the plant, according to Gov. Roy Cooper’s office. Eli Lilly has been instrumental in the development of insulin and COVID-19 treatments.
Lilly could receive $12.1 million in state payments if it meets the investment and job creation goals that formed the basis of an incentive reward. Concord and Cabarrus county leaders will hold meetings next month to consider performance-based property tax grants.
The company also announced in 2020 that it would build a factory in Research Triangle Park.
The Grounds, where Philip Morris once operated a factory, will also house a manufacturing, canning and distribution center operated by Red Bull, Rauch and Ball Corp. This announcement was made last summer.